Sage Therapeutics Inc Share Price

NASDAQ: SAGE

$8.70

(+-0.06%)

as on July 31, 2025 at 1:29 am IST

$₹

The stock has been delisted from the stock exchange on 30 Jul 2025

Sage Therapeutics Inc Stock Performance

as on July 31, 2025 at 1:29 am IST

Day's Low
$8.69
Day's Price Range
$8.7
$8.7
0.11%
Downside
52 Week's Low
52 Week's High
$4.62
52-Week Price Range
$9.36
$8.7
46.90%
Downside
7.59%
Upside

Sage Therapeutics Inc share price movements today

Previous Close: $8.70
Open: $8.70
Volume: 14.0K
Day's Low - High: $8.69 - $8.7
52 Week Low - High: $4.62 - $9.36

Sage Therapeutics Inc Historical Returns

1 Month Return: 0 %
3 Month Return: 0 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Sage Therapeutics Inc Stock Fundamentals & Key Indicators

Check Sage Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

EPS (TTM)

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

EBITDA

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

0.00%

Sage Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Sage Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Sage Therapeutics Inc	HOLD	$-	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$61.1B	256.98%	-505.15	-12.96%
Beone Medicines Ltd	NA	$38.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$101.1B	47.85%	28.07	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.4B	-3.43%	14.11	31.37%

Analyst Recommendation on Sage Therapeutics Inc Stock

Based on 27 analysts

HOLD

33.33%

Buy

62.96%

Hold

3.70%

Sell

Based on 27 analysts, 62.96% of analysts recommend a 'HOLD' rating for Sage Therapeutics Inc. Average target price of $8.71

Sage Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Sage Therapeutics Inc.

What analysts predicted

0.11%UPSIDE

Target Price

$8.71

Current Price

$8.7

Analyzed by

27 Analysts

Target

$8.71

Sage Therapeutics Inc target price $8.71, a slight upside of 0.11% compared to current price of $8.7. According to 27 analysts rating.

Sage Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Total Revenue	2	3	2	2	77	7	8	11	12	14
Gross Profit	2	3	2	1	77	6	7	6	11	13
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-133	-138	-160	-201	-32	-108	-102	-93	-95	-62
Net Profit Margin	-4652.95%	-4195.08%	-6480.40%	-7423.78%	-41.95%	-1372.85%	-1188.51%	-788.06%	-747.33%	-442.39%

Sage Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	90	6	1,114	6	7	86	41
Gross Profit	0	-120	-210	90	6	1,113	5	6	84	31
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-94	-158	-270	-372	-650	606	-450	-503	-541	-400
Net Profit Margin	0.00%	0.00%	0.00%	-413.06%	-9466.38%	54.40%	-7146.91%	-6547.84%	-626.32%	-971.48%

Global Institutional Holdings in Sage Therapeutics Inc

Funds	Holdings
Vanguard Group Inc	8.11%
BlackRock Inc	7.44%
Madison Avenue Partners, LP	7.15%
Caligan Partners LP	4.87%
Test Hedge Fund Mgmt	4.36%

See all

Insights on Sage Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 6 months, SAGE stock has moved up by 19.9%
POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 5 quarters, 7.90M → 14.06M (in $), with an average increase of 13.0% per quarter
POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -95.77M → -62.21M (in $), with an average increase of 54.0% per quarter
NO EFFECT
Against Peers
In the last 1 year, Beone Medicines Ltd has given 79.8% return, outperforming this stock by 100.4%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 78.2% return, outperforming this stock by 152.9%

About Sage Therapeutics Inc

Sage Therapeutics, Inc. is a biopharmaceutical company. The Company has developed two FDA-approved treatments indicated for postpartum depression (PPD) and is advancing a portfolio of internally discovered novel chemical entities with the potential to become differentiated treatments designed to improve brain health by primarily targeting two critical central nervous system, receptor systems, GABA and NMDA. Its product ZURZUVAE is for the treatment of PPD in adults. ZURZUVAE is a neuroactive steroid that is a positive allosteric modulator of GABAA receptors, targeting both synaptic and extrasynaptic GABAA receptors, and is the first oral, once-daily, 14-day treatment specifically indicated for adults with PPD. It is also evaluating potential indications for SAGE-324, a novel GABAA receptor positive allosteric modulator intended for chronic oral dosing, including seizures in developmental and epileptic encephalopathies. Its other areas of focus are SAGE-319, SAGE-039, and SAGE-817.

Organisation	Sage Therapeutics Inc
E-voting on shares	Click here to vote

FAQs

What is Sage Therapeutics Inc share price today?

Sage Therapeutics Inc share price today is $8.7 as on July 31, 2025 at 1:29 am IST at the close of the market. Sage Therapeutics Inc share today touched a day high of $8.7 and a low of $8.69.

What is the 52 week high and 52 week low for Sage Therapeutics Inc share?

Sage Therapeutics Inc share touched a 52 week high of $9.36 on July 11, 2025 and a 52 week low of $4.62 on November 20, 2024. Sage Therapeutics Inc stock price today i.e. July 31, 2025 at 1:29 am IST is closed at $8.7,which is 7.05% down from its 52 week high and 88.31% up from its 52 week low.

How to invest in Sage Therapeutics Inc Stock (SAGE) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Sage Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Sage Therapeutics Inc Shares that will get you 0.1724 shares as per Sage Therapeutics Inc share price of $8.7 per share as on July 31, 2025 at 1:29 am IST.

What is the minimum amount required to buy Sage Therapeutics Inc Stock (SAGE) from India?

Indian investors can start investing in Sage Therapeutics Inc (SAGE) shares with as little as ₹88.141 or $1 (as of September 16, 2025 at 3:06 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹881.41 in Sage Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on September 16, 2025 at 3:06 am IST). Based on Sage Therapeutics Inc share’s latest price of $8.7 as on July 31, 2025 at 1:29 am IST, you will get 1.1494 shares of Sage Therapeutics Inc. Learn more about fractional shares .